Cargando…

Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS

BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rammohan, Bera, Samit, Karmakar, Chinmoy, Das, Arup, Saha, Amit, Kundu, Ratul, Sarkar, Sanmoy, Karmakar, Dipan, Adhikari, Tuhinadri, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068113/
https://www.ncbi.nlm.nih.gov/pubmed/27761064
http://dx.doi.org/10.4103/0973-1296.191441
_version_ 1782460756695973888
author Rammohan, Bera
Samit, Karmakar
Chinmoy, Das
Arup, Saha
Amit, Kundu
Ratul, Sarkar
Sanmoy, Karmakar
Dipan, Adhikari
Tuhinadri, Sen
author_facet Rammohan, Bera
Samit, Karmakar
Chinmoy, Das
Arup, Saha
Amit, Kundu
Ratul, Sarkar
Sanmoy, Karmakar
Dipan, Adhikari
Tuhinadri, Sen
author_sort Rammohan, Bera
collection PubMed
description BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloroform and n-hexane) and deacylgymnemic acid (DGA) on human CYP1A2, 2C8, 2C9, 2D6 and 3A4 activities in HLM. MATERIAL AND METHODS: Probe substrate-based LCMS/MS method was established for all CYPs. The metabolite formations were examined after incubation of probe substrates with HLM in the presence or absence of extracts and DGA. The inhibitory effects of GS extracts and DGA were characterized with kinetic parameters IC50 and Ki values. RESULTS: GS extracts showed differential effect on CYP activities in the following order of inhibitory potency: ethyl acetate > Chloroform > methanol > n-hexane > aqueous > DGA. This differential effect was observed against CYP1A2, 2C9 and less on CYP3A4 and 2C8 but all CYPs were unaffected by aqueous extract and DGA. The ethyl acetate and chloroform extract exhibited moderate inhibition towards CYP1A2 and 3A4. The aqueous extract and DGA however showed negligible inhibition towards all five major human CYPs with very high IC50 values (>90μg/ml). CONCLUSION: The results of our study revealed that phytoconstituents contained in GS, particularly in ethyl acetate and chloroform extracts, were able to inhibit CYP1A2, 3A4 and 2C9. The presence of relatively small, lipophillic yet slightly polar compounds within the GS extracts may be attributed for inhibition activities. These suggest that the herb or its extracts should be examined for potential pharmacokinetic drug interactions in vivo. Abbreviations used: GS: Gymnema sylvestre, GSE: Gymnema sylvestre extract, DGA: deacyl gymnemic acid, CYP: cytochrome P450, DMSO: dimethylsulphoxide, HLM: human liver microsomes, LC-MS/MS: liquid chromatography tandem mass spectroscopy, NADPH: reduced nicotinamide adeninedinucleotide phosphate, NRS: nicotinamide adeninedinucleotide phosphate regenerating system, CHE: chloroform extract, EAE: ethyl acetate extract, NHE- n-hexane extract, AE: aqueous extract, ME: methanol extract
format Online
Article
Text
id pubmed-5068113
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50681132016-10-19 Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS Rammohan, Bera Samit, Karmakar Chinmoy, Das Arup, Saha Amit, Kundu Ratul, Sarkar Sanmoy, Karmakar Dipan, Adhikari Tuhinadri, Sen Pharmacogn Mag Original Article BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloroform and n-hexane) and deacylgymnemic acid (DGA) on human CYP1A2, 2C8, 2C9, 2D6 and 3A4 activities in HLM. MATERIAL AND METHODS: Probe substrate-based LCMS/MS method was established for all CYPs. The metabolite formations were examined after incubation of probe substrates with HLM in the presence or absence of extracts and DGA. The inhibitory effects of GS extracts and DGA were characterized with kinetic parameters IC50 and Ki values. RESULTS: GS extracts showed differential effect on CYP activities in the following order of inhibitory potency: ethyl acetate > Chloroform > methanol > n-hexane > aqueous > DGA. This differential effect was observed against CYP1A2, 2C9 and less on CYP3A4 and 2C8 but all CYPs were unaffected by aqueous extract and DGA. The ethyl acetate and chloroform extract exhibited moderate inhibition towards CYP1A2 and 3A4. The aqueous extract and DGA however showed negligible inhibition towards all five major human CYPs with very high IC50 values (>90μg/ml). CONCLUSION: The results of our study revealed that phytoconstituents contained in GS, particularly in ethyl acetate and chloroform extracts, were able to inhibit CYP1A2, 3A4 and 2C9. The presence of relatively small, lipophillic yet slightly polar compounds within the GS extracts may be attributed for inhibition activities. These suggest that the herb or its extracts should be examined for potential pharmacokinetic drug interactions in vivo. Abbreviations used: GS: Gymnema sylvestre, GSE: Gymnema sylvestre extract, DGA: deacyl gymnemic acid, CYP: cytochrome P450, DMSO: dimethylsulphoxide, HLM: human liver microsomes, LC-MS/MS: liquid chromatography tandem mass spectroscopy, NADPH: reduced nicotinamide adeninedinucleotide phosphate, NRS: nicotinamide adeninedinucleotide phosphate regenerating system, CHE: chloroform extract, EAE: ethyl acetate extract, NHE- n-hexane extract, AE: aqueous extract, ME: methanol extract Medknow Publications & Media Pvt Ltd 2016-07 /pmc/articles/PMC5068113/ /pubmed/27761064 http://dx.doi.org/10.4103/0973-1296.191441 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rammohan, Bera
Samit, Karmakar
Chinmoy, Das
Arup, Saha
Amit, Kundu
Ratul, Sarkar
Sanmoy, Karmakar
Dipan, Adhikari
Tuhinadri, Sen
Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title_full Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title_fullStr Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title_full_unstemmed Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title_short Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
title_sort human cytochrome p450 enzyme modulation by gymnema sylvestre: a predictive safety evaluation by lc-ms/ms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068113/
https://www.ncbi.nlm.nih.gov/pubmed/27761064
http://dx.doi.org/10.4103/0973-1296.191441
work_keys_str_mv AT rammohanbera humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT samitkarmakar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT chinmoydas humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT arupsaha humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT amitkundu humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT ratulsarkar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT sanmoykarmakar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT dipanadhikari humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms
AT tuhinadrisen humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms